Lilly pays Aktis $60M to further dial into radiopharma signal

May 21, 2024 · Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal By Nick Paul Taylor May 21, 2024 8:50am Eli Lilly radiopharmaceuticals Aktis Oncology Licensing deals

CouponFollow Extension

$60
OFF

Lilly Pays Aktis $60M To Further Dial Into Radiopharma Signal

4 weeks from now

May 21, 2024 · Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal By Nick Paul Taylor May 21, 2024 8:50am Eli Lilly radiopharmaceuticals Aktis Oncology Licensing deals

fiercebiotech.com

$60
OFF

Lilly Collaborates With Aktis To Strengthen Radiopharma Portfolio

4 weeks from now

May 21, 2024 · Lilly collaborates with Aktis to strengthen radiopharma portfolio. Aktis will receive $60m in an upfront payment from Lilly, with the biotech eligible for up to $1.1bn in milestone …

pharmaceutical-technology.com

$60
OFF

Eli Lilly Pays Aktis $60M Upfront To Further Dial Into Radiopharma …

4 weeks from now

May 21, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Eli Lilly has entered into a strategic multi-target discovery collaboration agreement with Aktis Oncology in a deal worth more than $1bn to develop novel anticancer …

pmlive.com

$60
OFF

Eli Lilly Inks Radiopharma Deal With Aktis (NYSE:LLY)

4 weeks from now

May 21, 2024 · Per the terms, Boston, Massachusetts-based Aktis will receive a $60M upfront payment, an equity investment from Eli Lilly , in addition to potential milestone payments worth …

seekingalpha.com

$60
OFF

Eli Lilly Pays $60M Upfront For Radiopharmaceutical Pact With Aktis

4 weeks from now

Under the terms of the agreement, Aktis will receive a $60M upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. In addition, Aktis will be …

tipranks.com

$1
OFF

Lilly Bolsters Radiopharmaceuticals Portfolio Through $1.1B ...

4 weeks from now

Indianapolis, IN, May 21, 2024 (msn.com) -- In a strategic move to bolster its presence in the radiopharmaceuticals domain, Eli Lilly has forged a multi-target discovery collaboration …

jacobsmgt.com

$60
OFF

Eli Lilly Pays $60M To Aktis For Radiopharma Investment

4 weeks from now

Jun 27, 2024 · Eli Lilly's foray into radiopharmaceuticals began to take shape with its acquisition of Point Biopharma for $1.4 billion last year. ... Lilly further enhanced its radiopharma assets by …

patsnap.com

$60
OFF

Lilly, Aktis Sign Radiopharmaceuticals Pact - Chemical

4 weeks from now

May 23, 2024 · Lilly will pay Aktis $60 million up front and up to $1.1 billion in milestones to discover the compounds and bring them through preclinical development. Lilly will then be …

acs.org

$60
OFF

Lilly, Aktis Sign Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

May 27, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

acs.org

$1
OFF

Eli Lilly Inks Radiopharma Deal Worth Up To $1.1B With Aktis - MSN

4 weeks from now

Per the terms, Boston, Massachusetts-based Aktis will receive a $60M upfront payment, an equity investment from Eli Lilly , in addition to potential milestone payments worth up to $1.1B.

msn.com

$140
OFF

Eli Lilly Continues Radiopharma Push With $140m Radionetics …

4 weeks from now

Jul 2, 2024 · The deal marks the latest push by Eli Lilly into the radiopharmaceuticals space. The company spent $1.4bn to buy POINT Biopharma in October 2023, gaining two late-stage …

pharmaceutical-technology.com

$175
OFF

Big Pharma Backers Return For Aktis' $175M Series B

4 weeks from now

Sep 30, 2024 · Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal

fiercebiotech.com

$60
OFF

Eli Lilly Pays Aktis $60M Upfront To Further Dial Into Radiopharma …

4 weeks from now

Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal news 📰 fiercebiotech.com Open. Share Add a Comment. Be the first to comment Nobody's responded to this post yet. …

reddit.com

FAQs about Lilly pays Aktis $60M to further dial into radiopharma signal Coupon?

How much money will aktis receive from Lilly?

Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. In addition, Aktis will be eligible to receive up to an additional $1.1 billion in potential preclinical, clinical, regulatory and commercial milestones, as well as tiered royalties. ...

What is aktis oncology doing with Eli Lilly?

Privately held biotech Aktis Oncology announced Tuesday a collaboration agreement with Eli Lilly ( NYSE: LLY) to develop cancer-targeting radiopharmaceutical drugs in a deal worth up to $1.1B in terms of milestone payments alone. ...

What rights does Lilly receive from aktis?

In exchange, Lilly will receive worldwide rights to develop radiopharmaceutical therapeutic and diagnostic products discovered by Aktis on a defined set of targets selected by Lilly. ...

Will Lilly acquire aktis pharmaceuticals?

Under the terms of the agreement, Lilly will gain worldwide rights to develop targets for radiopharmaceuticals discovered by Aktis. However, the deal does not include Aktis’ current pipeline, which consists of seven programmes. ...

Is aktis the future of radiopharma?

While Novartis has established the modern radiopharma field with beta-emitting drugs, namely Pluvicto and Luthatera, Aktis sees more potent alpha emitters as the future of the sector. The biotech is combining its radioactive isotopes with miniproteins. ...

Will Eli Lilly buy radionetics oncology for $140 million?

Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G protein coupled receptor (GPCR) targeted drugs. ...